Trialbee (private company)

See something wrong or missing? Let us know
Offices:
Malmö
Business model:
B2B
Key People:
Tobias Folkesson
Investors:
we tracked 5 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 4 transactions

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Trialbee is a dynamic software company with a single purpose of accelerating clinical research by delivering solutions and services to the pharmaceutical industry.

We provide innovative software solutions that optimize the clinical trial process by enabling all stakeholders to easily communicate and collaborate on a joint platform.

The company was founded in 2010 with the development of a method to increase speed and accuracy of patient recruitment to clinical trials.

Patients, who participate in clinical trials, are often aware and engaged. Yet, in order to participate hurdles should be kept at a minimum. These principles are the basis for our suite of products for capture and management of study data. Our solution has evolved through careful testing to become a truly user friendly patient centric system. Our expertise in user experience and database design ensure that users will experience a revolutionary system.

Companies with similar profile to Trialbee:

CompanyCriteria
Sweden AMRA
55%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden OxThera
55%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Spain Oncomatryx
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Spain Bigfinite
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark NMD Pharma
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Asarina Pharma
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Spain Sanifit Therapeutics
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark STipe Therapeutics
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark AFYX Therapeutics
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden ITBMed
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Forendo Pharma
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Blueprint Genetics
53%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: MTIP - MedTech Innovation Partners
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Athera
46%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
Sweden Gesynta Pharma
46%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
Sweden InDex Pharmaceuticals
45%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 10M+ USD
Sweden BoneSupport
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 10M+ USD
Norway Smartfish
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 10M+ USD
Sweden Airsonett
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 10M+ USD
Sweden Vint
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one angel investor: Hampus Jakobsson
  • Minim one investor from outside Scandinavia: Yes
Sweden Elypta
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Minim one investor from outside Scandinavia: Yes